Kincell Bio and Cellipont merger forming Kincellis

Kincell Bio and Cellipont Bioservices completed their merger to form Kincellis Advanced Therapies. NewSpring led equity financing with existing investors Kineticos Life Sciences, HealthQuest Capital and Great Point Partners. J.P. Morgan provided a debt facility; William Blair advised Cellipont. Financial terms were undisclosed.